In this episode of GEN's Touching Base, editors talk about neuroscience research updates, insights into how investors are approaching the changing AI landscape, and business updates on profits and buyouts. The post Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Gene Therapy Partners Aim to Enhance Protein Expression
Modular Antibody–ADC Click Chemistry Overcomes Tumor...
See, Blind Mice: Consortium’s Drugs Restore Sight
Jasper gets a lifeline in merger with immune drugmaker...
Arbutus, Sanofi escalate mRNA patent fights;...
GSK shelves cough drug acquired in $2B deal
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.